Each capsule contains: Carbocisteine 500 mg.
Pharmacology: Carbocisteine is a new mucosolvent for the management of cough and other disorders of the respiratory passages associated with the production of excessive and tenacious bronchial secretions. It also affects bronchial secretion by increasing its volume, reducing its viscosity, decreasing the aggregation tendencies of mucopolysaccharides and breaking the disulfide bonds of the mucous peptide chains. In addition, Carbocisteine evidently affects the intracellular synthesis of the mucins by activating sualyl transferase enzymes. It was found that the volume of mucus increased, the pourability of mucus improved; and the patients' subjective well-being improved considerably faster by the effect of treatment with Carbocisteine. Its unique action makes Carbocisteine a superior mucofluidifying agent. It provides clinical improvement of cough four days ahead of Bromhexine. It increases ventilatory volumes and helps resolve the inflammatory processes of the bronchial mucous membrane. Carbocisteine is very safe. There is no contraindication reported, but in some patients it may inhibit stomach irritation as side effect.
For the treatment of disorders of the respiratory tract associated with excessive mucus.
CAPSULE 500 mg: Adult: 1 capsule every 8 hours or as prescribed by the physician.
Active peptic ulcer, concomitant administration of antitussive.
Nausea, headache, gastric discomfort, diarrhea, gastrointestinal bleeding, and skin rash occasionally occurred with Carbocisteine.
Store at temperatures not exceeding 30°C.
Protect from light.
R05CB03 - carbocisteine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.